A previously described agar-diffusion technique for microbioassay of antimicrobial agents has been modified to increase sensitivity of the technique and to extend the range of antimicrobial agents to which it is applicable. This microtechnique requires only 0.02 ml of an unknown test sample for assay, and is capable of measuring minute concentrations of antibiotics in buffer, serum, and urine. In some cases, up to a 20-fold increase in sensitivity is gained relative to other published standardized methods and the error of this method is less than -5 %. Buffer standard curves have been established for this technique, concurrently with serum standard curves, yielding information on antimicrobial serum-binding and demonstrating linearity of the data points compared to the estimated regression line for the microconcentration ranges covered by this technique. This microassay technique is particularly well suited for pediatric research and for other investigations where sample volumes are small and quantitative accuracy is desired. Dilution of clinical samples to attain concentrations falling with the range of this assay makes the technique readily adaptable and suitable for general clinical pharmacological studies. The microassay technique has been standardized in buffer solutions and in normal human serum pools for the following antimicrobials: ampicillin, methicillin, penicillin G, oxacillin, cloxacillin, dicloxacillin, cephaloglycin, cephalexin, cephaloridine, cephalothin, erythromycin, rifamycin amino methyl piperazine, kanamycin, neomycin, streptomycin, colistin, polymyxin B, doxycycine, minocycline, oxytetracycline, tetracycline, and chloramphenicol.
Standard agar-diffusion bioassays for antimicrobial agents require greater volumes of blood and other body fluids than can safely be obtained in serial samples from premature infants, diverse body cavities, collections of exudates, or from small animals (5) . Other antibiotic assay methods require at least twice the sample volume (1, 3) and do not attain the degree of sensitivity offered by this technique. The microassay technique described in this study was originally developed for clinical pharmacological studies in newborn and premature infants (2) . It requires only 0.02 ml of sample material and has been standardized to yield results within a ±5% range of error.
Statistical analysis of the correlation of data points on bioassay standard curves and calculation of serum half-life values of drugs in clinical studies have been speedily attained by a simple adaptation of the data to utilize prewritten programs for the Olivetti Underwood Programma 101, a programmable calculator (7) .
MATERIALS AND METHODS Preparation of standard curves. Measured suspensions of test organisms (Tables 1 and 2) were inoculated into sterile melted agar cooled to and maintained at 50 C. On a critically leveled surface, a continuous pipetting apparatus (B-D Cornwall Continuous Pipetting Outfit) is used to distribute 6-ml volumes of the inoculated agar to sterile glass Petri dish bottoms (Pyrex no. 3162). These are then covered with Brewer Petri dish tops fitted with absorbent cardboard liners , and the agar is allowed to solidify. After the agar has solidified, blank, previously autoclaved, sterile 6.5-mm diameter discs (Schleicher & Schuell Co., Keene, N.H., no. 740E) are placed on the agar surface at 60-degree intervals on a 28 mm radius.
Only freshly prepared plates are used. The bulk cultures of test organisms (5) are prepared biweekly and stored at 4 C. Samples of suspensions are standardized colorimetrically just before use, a procedure taking but a few minutes and contributing significantly to reproducibility of the assay.
Known-potency preparations of antimicrobials to be assayed are diluted in appropriate buffers (4) (5) (6) or in a normal human serum pool to provide concentrations of standards within the limits of the testing range (Table 3) . These standard concentrations are freshly prepared for each set of determinations. the inaccuracies of serial twofold dilutions, as discussed by other investigators (3) . The general dilution scheme is similar to that of Bennett et al. (3) , except that the final concentrations for the standard curve are prepared from the highest concentration actually used in the standard curve. For example, the dilution scheme for the penicillin G standard curve is as follows: (i) 2.0 ml of penicillin G in diluent at 0.4 units/ml; (ii) 0.6 ml of (i) + 0.2 ml of diluent = 0.3 units/ml; (iii) 0.5 ml of (i) + 0.5 ml of diluent = 0.2 units/ml; (iv) 0.3 ml of (i) + 0.5 ml of diluent = 0.15 units/ml; (v) 0.2 ml of (i) + 0. 4 .0 units/ml, 10 times the normal final concentration. Succeeding standard curve concentrations would therefore also be 10 times the final concentration in the serum pool diluent. The modified dilution scheme would be as follows: (i) 0.05 ml of 4.0 units/ml in serum pool plus 0.45 ml patient serum = 0.4 units/ml; (ii) 0.05 ml of 3.0 units/ml in serum pool plus 0.45 ml patient serum = 0.3 units/ml; (iii) 0.1 ml of 2.0 2.0 units/ml in serum pool plus 0.9 ml patient serum = 0.2 units/ml; (iv) 0.05 ml of 1.5 units/ml in serum pool plus 0.45 ml patient serum = 0.15 units/ml; (v) 0.05 ml of 1.0 units/ml in serum pool plus 0.45 ml of patient serum = 0.1 units/ml. Establishment of a five-point standard curve in 90% patient's control serum would thus require only 2.7 ml of the patient's control serum.
Analysis of data. In the past, time-consuming and tedious calculations commonly performed manually were often necessary for estimating a regression line from sample data. Because the sample data for the 2/,3 where T12 is the serum half-life and is the rate constant for decrease in serum concentrations.
RESULTS
Accurate and reproducible standard buffer and serum curves have been established for ampicillin, methicillin, penicillin G, oxacillin, cloxacillin, dicloxacillin, cephaloglycin, cephalexin, cephaloridine, cephalothin, erythromycin, rifamycin amino methyl piperazine (AMP), kanamycin, streptomycin, neomycin, colistin, polymixin B, doxycycline, minocycine, oxytetracycline, tetracycline, and chloramphenicol. (Fig. 1 and 2 ). The figures are presented because they graphically show relative slopes of the buffer standard curves. These reproducible curves, together with the data presented in Table 4 , will enable an investigator wishing to use this technique to assess his ability to use this technique and to determine whether experimental samples require dilution.
Slopes of buffer and serum standard curves for each antimicrobial were subjected to standard statistical analysis for parallelism. At P = 0.01, there was no significant difference between slopes of the buffer and serum standard curves in the concentration ranges covered by this microtechnique. On the assumption of parallelism, a serumbinding percentage for in vitro dilutions of antimicrobials in human serum has been calculated for the mean concentration of each standard curve (Table 4) .
DISCUSSION
Since the filter-paper discs measure 6.5 mm in diameter, growth inhibition zones of less than 7.5 mm diameter cannot be read with accuracy. The 7.5-mm zone of inhibition thus determines the lowest concentration of drug that can be accurately measured with this assay (Table 4 ). The highest concentrations of the standards listed in Table 3 are arbitrary. Generally, an upper limit is determined by a zone diameter which stops just short of interfering with neighboring zones produced by the reference standard. Higher concentrations have been assayed either with use of a lower concentration for the reference standard or by increasing the dilution factor for the unknowns.
A microassay technique with filter-paper discs has been employed by Bristol Laboratories (personal communication) for studies with dicloxacillin. According to the description, a filter-paper disc is dipped into an antimicrobial-containing solution to saturation. Our experience with the "dipping" method was unsatisfactory. A disc may absorb from 0.03 to 0.05-ml of test material. Thus, actual concentrations on discs said to contain identical concentrations may actually differ widely from each other-evidenced by greatly differing zones of inhibition-because the subjective judgment of the individual performing the assay is used to determine a saturation point.
In this microassay system, the minimal detectable concentrations for chloramphenicol are 9.0 ,ug/ml in buffer and 10.9 ,g/ml in serum 
